| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.081 | 0.6 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |